查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
远端患者监护(RPM) 市场按组件、适应症、最终用户和地区划分 - 预测至 2030 年
市场调查报告书
商品编码
1660134

远端患者监护(RPM) 市场按组件、适应症、最终用户和地区划分 - 预测至 2030 年

Remote Patient Monitoring (RPM) Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 396 Pages | 订单完成后即时交付

价格

全球远端患者监护市场规模预计将从 2024 年的 277.2 亿美元成长到 2030 年的 569.4 亿美元，2024 年至 2030 年的复合年增长率为 12.7%。

远端患者监护市场成长的原因：越来越多的人患有医院获得性感染（HAI），例如血液感染疾病、尿道感染、肺炎和艰难梭菌引起的感染疾病。这些感染疾病与医院内的严重健康併发症和死亡有关，因此远端病人监控解决方案对于预防和管理风险是必不可少的。此外，心血管疾病、肥胖症和糖尿病等慢性病的发生率不断上升，推动了对有效的远端监控技术的需求。美国的医疗成本急剧上升，近一半的成年人无力负担处方药和看诊费用。这些经济问题使得使用远端患者监护技术成为一项挑战，因为患者难以负担基本医疗服务的费用，因此更无力购买新的数位工具。

研究范围
调查年份 2022-2030
基准年 2023
预测期 2024-2030
考虑单位 金额（美元）
部分 按成分、按适应症、按最终用户、按地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

预计到 2023 年，云端基础的部署将成为远端患者监护市场成长最快的部分。主要原因是这种模式具有多种优点，例如易于整合来自多个云端来源的资料、远端用户无限制存取、维护成本低、安全性和隐私性高、易于存取、无需预先购买硬体以及容量和资源使用具有极大的灵活性。透过云端基础的模型可以实现多种用途，其核心功能如会计、绩效管理、网路邮件和即时通讯软体都被证明有助于推动这一特定领域的发展。

远端患者监护市场分为五个主要地理区域：北美、欧洲、亚太、拉丁美洲以及中东和非洲。北美在远端患者监护市场占据主导地位，原因如下：医疗技术的采用率明显较高、医疗保健基础设施强大而完善，以及为支持这些进步而不断增加的医疗保健支出。此外，患者患慢性病的趋势和对家庭医疗保健解决方案日益增长的需求也有望推动该地区市场的成长。根据美国卫生与公共服务部监察长办公室的一份报告，接受 RPM 的 Medicare用户将增加十倍以上，从 2019 年的 55,000 人增加到 2022 年的 570,000 人，这表明采用率显着提高。

本报告研究了全球远端患者监护(RPM) 市场，并按组件、适应症、最终用户、地理位置和参与市场的公司概况进行细分。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章 市场概况

  • 介绍
  • 影响客户业务的趋势/干扰
  • 产业趋势
  • 生态系分析
  • 价值链分析
  • 技术分析
  • 资费与监理分析
  • 贸易分析
  • 定价分析
  • 波特五力分析
  • 专利分析
  • 主要相关人员和采购标准
  • 最终用户分析
  • 2025-2026 年重要会议与活动
  • 案例研究分析
  • 投资金筹措场景
  • 远端患者监护经营模式
  • 生成式人工智慧/人工智慧对远端患者监护市场的影响
  • 赎回情况

第六章远端患者监护市场（按组件）

  • 介绍
  • 装置
  • 软体
  • 服务

第七章远端患者监护市场（按适应症）

  • 介绍
  • 瘤
  • 心臟病
  • 神经
  • 糖尿病
  • 睡眠障碍
  • 呼吸系统疾病
  • 健康促进
  • 心理健康
  • 其他的

第 8 章远端患者监护市场（按最终用户）

  • 介绍
  • 医疗保健提供者
  • 医疗保健付款人
  • 病人
  • 製药和生物技术公司
  • 医疗科技公司
  • 其他的

第九章远端患者监护市场（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 中国
    • 日本
    • 印度
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
  • 中东和非洲宏观经济展望
    • 海湾合作委员会国家
    • 其他的

第十章 竞争格局

  • 概述
  • 主要参与企业的策略/优势
  • 2019 至 2023 年收益分析
  • 2023 年市场占有率分析
  • 公司估值矩阵：主要参与企业，2023 年
  • 公司估值矩阵：Start-Ups/中小企业，2023 年
  • 估值及财务指标
  • 品牌/软体比较
  • 竞争场景

第十一章 公司简介

  • 主要参与企业
    • KONINKLIJKE PHILIPS NV
    • OMRON HEALTHCARE, INC.（SUBSIDIARY OF OMRON CORPORATION）
    • MEDTRONIC
    • GE HEALTHCARE
    • ABBOTT
    • ORACLE
    • BOSTON SCIENTIFIC CORPORATION
    • NIHON KOHDEN CORPORATION
    • SIEMENS HEALTHINEERS AG
    • BAXTER
    • BIOBEAT
    • BIOTRONIK
    • VITALCONNECT
    • VIVALNK, INC.
    • CLEARARCH, INC.
    • OPTUM, INC.（VIVIFY HEALTH, PART OF OPTUM）
    • BLUE SPARK TECHNOLOGIES, INC.
    • LIGHTBEAM
    • CLOUD DIAGNOSTICS CANADA ULC
    • TELADOC HEALTH, INC.
    • GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.
  • 其他公司
    • CARESIMPLE INC.
    • TIMEDOC, INC.
    • MD REVOLUTION INC.
    • OPTIMIZE HEALTH, INC.
    • HEALTH RECOVERY SOLUTIONS

第十二章 附录

Product Code: HIT 7776

The global remote patient monitoring market is projected to reach USD 56.94 billion by 2030 from 27.72 billion in 2024, at a CAGR of 12.7% from 2024 to 2030. Reason for growth in the remote patient monitoring market: More individuals are getting hospital-acquired infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and infections caused by C. difficile. These infections have been associated with critical health complications and death in hospitals, hence the solutions that monitor patients remotely have been necessary in the prevention and management of risks. Further, the incidence of chronic diseases such as cardiovascular diseases, obesity, and diabetes is rising, which in turn increases the demand for effective remote monitoring technologies. The cost of healthcare in the US has substantially deteriorated; almost half of US adults are struggling to afford prescription drugs and doctor visits. This affordability issue challenges patients to use remote patient monitoring technologies since they are experiencing difficulties coming up with money for basic healthcare services, not to mention coming up with money for new digital tools.

Scope of the Report
Years Considered for the Study2022-2030
Base Year2023
Forecast Period2024-2030
Units ConsideredValue (USD)
SegmentsComponent, Indication, and End-user
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

"Cloud based deployment is the fastest segment in the remote patient monitoring software by deployment market in 2023"

Cloud-based deployment is expected to be the fastest-growing segment in the remote patient monitoring market during 2023, mainly because this model has several advantages, such as easy integration of data from multiple cloud sources, unlimited access by users from remote locations, low maintenance costs, high security and privacy, easy access, no need to buy hardware up front, and excellent flexibility in the use of capacity and resources. A plethora of applications made accessible through the cloud-based model with core functionalities involving accounting, performance management, and also webmails and instant messages are all proving to be helpful in fueling this particular portion.

"North America dominated the remote patient monitoring market in 2023."

The remote patient monitoring market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American region dominated the remote patient monitoring market because of several factors such as substantially high adoption rates of healthcare technologies, a robust and well-established infrastructure in healthcare, and constant growth in healthcare spending that supports such progress. In addition, the increasing trend in the chronic diseases patients suffer from and the increasing need for home healthcare solutions will also increase growth in this region's market. According to the Department of Health and Human Services' Office of Inspector General report, that Medicare enrolees receiving RPM increased more than 10-fold from 55,000 in 2019 to 570,000 in 2022, indicating a substantial increase in adoption.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
  • By Designation - C-level: 35%, Director-level: 40%, and Others: 25%
  • By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.

Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Baxter (US), Biobeat (Israel), Biotronik (Germany), and VitalConnect (US) are some of the key players in the remote patient monitoring market.

  • The study includes an in-depth competitive analysis of these key players in the remote patient monitoring market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the remote patient monitoring market by component (devices by function [cardiac monitoring devices, neurological monitoring devices, respiratory monitoring devices, blood glucose monitoring devices, fetal & neonatal monitoring devices, weight monitoring devices, multiparameter monitoring devices, pulse oximeter devices, thermometers, other monitoring devices (rehabilitation and physical therapy devices, fall detection devices, and others)], by product type- [wearable devices, implantable devices, handheld & portable devices, others (stationary devices, and others)], software by deployment- [on-premise model and cloud-based model], by transmission type- [synchronous and asynchronous], and services). By indication (oncology, cardiology, neurology, diabetes, sleep disorders, respiratory diseases, wellness improvement (weight management, fitness monitoring, hydration monitoring, nutritional tracking & monitoring, etc), mental health, and others (obstetrics & gynecology, immunology, infectious diseases, metabolic disorders, ophthalmology, gastroenterology, nephrology & urology, hematology, endocrinology, musculoskeletal disorders, and others)). By end user (healthcare providers [hospitals, ambulatory surgical centers, ambulatory care centers, and other outpatient settings, long term care & assisted living facilities, home healthcare, and other healthcare providers (diagnostics & imagining centers, rehabilitation centers, behavioural health centers, and others)], healthcare payers, patients, pharmaceutical & biotechnology companies, medTech companies, and other end users (employer groups, government organizations, academic institutes, research centers, and others)), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the remote patient monitoring market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; partnerships, agreements. new product & service launches, regulatory approval, investment, fundings, mergers and acquisitions, and recent developments associated with the remote patient monitoring market. Competitive analysis of upcoming startups in the remote patient monitoring market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the remote patient monitoring market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (transforming patient care through digital innovation, telehealth driving growth in remote patient monitoring, rising prevalence of chronic diseases, growing geriatric population globally, need for cost-containment and improved patient care in healthcare industry, and wearables, health apps and connected devices enhancing remote patient monitoring solutions) restraints (high investments and lack of it expertise, behavioral barriers and healthcare affordability challenges in remote patient monitoring, and regulatory barriers in 2024 medicare policies impacting remote patient monitoring) opportunities (emergence of AI & ML, growing shift toward outpatient care environments, growing use in combating infectious diseases and enhanced patient care through early detection, hospital-at-home, and enhanced patient care through early detection and continuous monitoring) challenges (growing data security concerns data security issues, data accessibility issues, and integration of social determinants of health (sdoh) factors into rpm programs) influencing the growth of the remote patient monitoring market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the remote patient monitoring market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the remote patient monitoring market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the remote patient monitoring market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), and Siemens Healthineers AG); among others in the remote patient monitoring market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 SUPPLY-SIDE ANALYSIS
    • 2.2.2 BOTTOM-UP APPROACH: END-USER ADOPTION
    • 2.2.3 TOP-DOWN OF PARENT MARKET ASSESSMENT
    • 2.2.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
    • 2.4.1 MARKET SIZING ASSUMPTIONS
    • 2.4.2 OVERALL STUDY ASSUMPTIONS
  • 2.5 RISK ASSESSMENT
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 REMOTE PATIENT MONITORING MARKET OVERVIEW
  • 4.2 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER AND REGION (2023)
  • 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 REMOTE PATIENT MONITORING MARKET: DEVELOPED MARKETS VS. EMERGING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
    • 5.1.1 DRIVERS
      • 5.1.1.1 Transformation of patient care through digital innovation
      • 5.1.1.2 Expansion of telehealth in remote patient monitoring
      • 5.1.1.3 Rising prevalence of chronic diseases
      • 5.1.1.4 Increasing geriatric population and rising uptake of RPM services
      • 5.1.1.5 Growing need for cost-containment across healthcare facilities
      • 5.1.1.6 Technological innovation in wearables, mhealth apps, and connected devices
    • 5.1.2 RESTRAINTS
      • 5.1.2.1 High investments and lack of IT expertise
      • 5.1.2.2 Behavioral barriers and healthcare affordability challenges in remote patient monitoring
      • 5.1.2.3 Challenges associated with 2024 CMS regulations
    • 5.1.3 OPPORTUNITIES
      • 5.1.3.1 Emergence of AI & ML
      • 5.1.3.2 Gradual shift toward outpatient care environments
      • 5.1.3.3 Increasing utilization for infectious disease diagnostics
      • 5.1.3.4 Rising initiatives for hospital-at-home programs
    • 5.1.4 CHALLENGES
      • 5.1.4.1 Concerns associated with data security
      • 5.1.4.2 Data accessibility issues
      • 5.1.4.3 incorporation of SDOH factors into RPM programs
  • 5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.2.1 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR REMOTE PATIENT MONITORING MARKET
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 GRADUAL SHIFT TO VALUE-BASED & PATIENT-CENTRIC CARE
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    • 5.6.1 KEY TECHNOLOGIES
      • 5.6.1.1 Miniature wearable devices
      • 5.6.1.2 Artificial intelligence & machine learning
      • 5.6.1.3 Cloud computing
      • 5.6.1.4 Patient engagement tools
      • 5.6.1.5 EHR integration
      • 5.6.1.6 Voice assistant integration
    • 5.6.2 COMPLEMENTARY TECHNOLOGIES
      • 5.6.2.1 5G connectivity
      • 5.6.2.2 mHealth apps
      • 5.6.2.3 Digital therapeutics
      • 5.6.2.4 Telehealth platforms
    • 5.6.3 ADJACENT TECHNOLOGIES
      • 5.6.3.1 POC diagnostics
      • 5.6.3.2 Smart home health devices
  • 5.7 TARIFF & REGULATORY ANALYSIS
    • 5.7.1 TARIFF DATA (HS CODE 9018)
    • 5.7.2 TARIFF DATA (HS CODE 9021)
    • 5.7.3 TARIFF DATA (HS CODE 9022)
    • 5.7.4 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
    • 5.7.5 REGULATORY ANALYSIS
  • 5.8 TRADE ANALYSIS
    • 5.8.1 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 90189099)
    • 5.8.2 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 9021)
    • 5.8.3 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 9022)
  • 5.9 PRICING ANALYSIS
    • 5.9.1 INDICATIVE PRICING FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2023)
    • 5.9.2 INDICATIVE PRICE FOR REMOTE PATIENT MONITORING DEVICES (2023)
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
    • 5.10.1 THREAT OF NEW ENTRANTS
    • 5.10.2 THREAT OF SUBSTITUTES
    • 5.10.3 BARGAINING POWER OF MANUFACTURERS
    • 5.10.4 BARGAINING POWER OF BUYERS
    • 5.10.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.11 PATENT ANALYSIS
    • 5.11.1 PATENT PUBLICATION TRENDS FOR REMOTE PATIENT MONITORING
    • 5.11.2 JURISDICTION AND TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING
    • 5.11.3 LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.12.2 BUYING CRITERIA
  • 5.13 END-USER ANALYSIS
    • 5.13.1 UNMET NEEDS
    • 5.13.2 END-USER EXPECTATIONS
  • 5.14 KEY CONFERENCES AND EVENTS, 2025-2026
    • 5.14.1 REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025-2026
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 REMOTE PATIENT MONITORING PORTAL AUTOMATION
      • 5.15.1.1 Case 1: Cost savings and performance boost through automation
    • 5.15.2 PATIENT MONITORING PORTAL AUTOMATION
      • 5.15.2.1 Case 2: RPM drives engagement and generates substantial returns
  • 5.16 INVESTMENT AND FUNDING SCENARIO
  • 5.17 REMOTE PATIENT MONITORING BUSINESS MODEL
    • 5.17.1 SUBSCRIPTION-BASED MODELS
    • 5.17.2 PLATFORM AS A SERVICE (PAAS)
    • 5.17.3 FREEMIUM MODELS WITH PREMIUM FEATURES
    • 5.17.4 COLLABORATIVE ECOSYSTEMS & PARTNERSHIPS
  • 5.18 IMPACT OF GENERATIVE AI/AI ON REMOTE PATIENT MONITORING MARKET
    • 5.18.1 KEY USE CASES
    • 5.18.2 CASE STUDIES FOR GENERATIVE AI/AI IMPLEMENTATION
      • 5.18.2.1 Case study 1: Enhancing remote patient monitoring for cancer treatment with NLP and HIPAA-compliant annotation
      • 5.18.2.2 Case study 2: Leveraging AI for proactive infection prevention in hospitals
    • 5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS
      • 5.18.3.1 Telehealth & telemedicine
      • 5.18.3.2 Wearable devices
      • 5.18.3.3 Digital healthcare
      • 5.18.3.4 Home healthcare
    • 5.18.4 USER READINESS & IMPACT ASSESSMENT
      • 5.18.4.1 User readiness
        • 5.18.4.1.1 User A: Hospitals
        • 5.18.4.1.2 User B: Ambulatory surgery centers
      • 5.18.4.2 Impact assessment
        • 5.18.4.2.1 User A: Hospitals
          • 5.18.4.2.1.1 Implementation
          • 5.18.4.2.1.2 Impact
        • 5.18.4.2.2 User B: Ambulatory surgery centers
          • 5.18.4.2.2.1 Implementation
          • 5.18.4.2.2.2 Impact
  • 5.19 REIMBURSEMENT SCENARIO

6 REMOTE PATIENT MONITORING MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
  • 6.2 DEVICES
    • 6.2.1 BY FUNCTION
      • 6.2.1.1 Cardiac monitoring devices
        • 6.2.1.1.1 Increasing uptake of ECG monitors and rising cases of hypertension to fuel market
      • 6.2.1.2 Neurological monitoring devices
        • 6.2.1.2.1 Growing demand for clinical-grade wearable devices for routine monitoring to drive market
      • 6.2.1.3 Respiratory monitoring devices
        • 6.2.1.3.1 Rising demand for peak flow meters and sleep apnea monitors to fuel market
      • 6.2.1.4 Blood glucose monitoring devices
        • 6.2.1.4.1 Increasing prevalence of diabetes to support market growth
      • 6.2.1.5 Fetal & neonatal monitoring devices
        • 6.2.1.5.1 Growing focus on vital health monitoring in preterm births to drive market
      • 6.2.1.6 Weight monitoring devices
        • 6.2.1.6.1 High incidence of obesity and growing advancements in smart weighing scales to fuel market
      • 6.2.1.7 Multiparameter monitoring devices
        • 6.2.1.7.1 Measurement of spO2, blood sugar, and respiratory activity to fuel uptake
      • 6.2.1.8 Pulse oximeter devices
        • 6.2.1.8.1 Rising demand in preoperative & home care settings to support market growth
      • 6.2.1.9 Thermometers
        • 6.2.1.9.1 Growing focus on home healthcare to fuel market
      • 6.2.1.10 Other monitoring devices
    • 6.2.2 BY TYPE
      • 6.2.2.1 Wearable devices
        • 6.2.2.1.1 Ability to provide real-time insights to drive market
      • 6.2.2.2 Implantable devices
        • 6.2.2.2.1 Advancements in wireless communication technologies to boost demand
      • 6.2.2.3 Handheld & portable devices
        • 6.2.2.3.1 Growing focus on device miniaturization to fuel market
      • 6.2.2.4 Other devices
  • 6.3 SOFTWARE
    • 6.3.1 SOFTWARE, BY DEPLOYMENT MODEL
      • 6.3.1.1 On-premise models
        • 6.3.1.1.1 Enhanced control, data security, and customization benefits to fuel market
      • 6.3.1.2 Cloud-based models
        • 6.3.1.2.1 Real-time data sharing and high-security features to boost demand
    • 6.3.2 SOFTWARE, BY TRANSMISSION TYPE
      • 6.3.2.1 Synchronous transmission
        • 6.3.2.1.1 Growing availability of real-time data analytics to boost demand
      • 6.3.2.2 Asynchronous transmission
        • 6.3.2.2.1 Increasing need for low-resource flexible solutions to support market growth
  • 6.4 SERVICES
    • 6.4.1 EXPANSION OF TELEMEDICINE PLATFORMS AND INTEGRATION OF SERVICE MODELS TO SUPPORT MARKET GROWTH

7 REMOTE PATIENT MONITORING MARKET, BY INDICATION

  • 7.1 INTRODUCTION
  • 7.2 ONCOLOGY
    • 7.2.1 GROWING FOCUS ON EARLY DISEASE DETECTION TO DRIVE MARKET
  • 7.3 CARDIOLOGY
    • 7.3.1 HIGH INCIDENCE OF CVD TO PROPEL MARKET
  • 7.4 NEUROLOGY
    • 7.4.1 INCREASING PREVALENCE OF NEUROLOGICAL CONDITIONS TO FUEL MARKET
  • 7.5 DIABETES
    • 7.5.1 GROWING FOCUS ON TELEHEALTH CONSULTATIONS FOR DIABETES MANAGEMENT TO BOOST DEMAND
  • 7.6 SLEEP DISORDERS
    • 7.6.1 INCREASING INCIDENCE OF SLEEP APNEA TO SUPPORT MARKET GROWTH
  • 7.7 RESPIRATORY DISEASES
    • 7.7.1 RISING CASES OF COPD AND ASTHMA TO FUEL MARKET
  • 7.8 WELLNESS IMPROVEMENT
    • 7.8.1 UTILIZATION OF WEIGHT MANAGEMENT & PERSONAL HEALTH APPS TO SUPPORT MARKET GROWTH
  • 7.9 MENTAL HEALTH
    • 7.9.1 GROWING FOCUS ON DEVELOPMENT OF PREDICTIVE HEALTH MODELS FOR COGNITIVE THERAPY TO PROPEL MARKET
  • 7.10 OTHER INDICATIONS

8 REMOTE PATIENT MONITORING MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HEALTHCARE PROVIDERS
    • 8.2.1 HOSPITALS
      • 8.2.1.1 Ability to purchase technologically advanced telehealth devices to fuel market
    • 8.2.2 ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS
      • 8.2.2.1 Increasing demand for cost-effective perioperative devices to fuel market
    • 8.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES
      • 8.2.3.1 Expanding geriatric population and growing focus on chronic disease management to fuel market
    • 8.2.4 HOME HEALTHCARE
      • 8.2.4.1 Growing preference for remote care to drive market
    • 8.2.5 OTHER HEALTHCARE PROVIDERS
  • 8.3 HEALTHCARE PAYERS
    • 8.3.1 LOW COSTS AND IMPROVED HEALTHCARE FACILITIES TO DRIVE MARKET
  • 8.4 PATIENTS
    • 8.4.1 INCREASING FOCUS ON AI INTEGRATION INTO WEARABLE DEVICES TO BOOST DEMAND
  • 8.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.5.1 RISING NEED FOR ENHANCED CLINICAL TRIAL OUTCOMES TO SUPPORT MARKET GROWTH
  • 8.6 MEDTECH COMPANIES
    • 8.6.1 INTEGRATION OF RPM WITH MEDTECH SOLUTIONS FOR DIAGNOSTIC ACCURACY TO FUEL MARKET
  • 8.7 OTHER END USERS

9 REMOTE PATIENT MONITORING MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 Supportive regulatory frameworks for AI implementation in wearable devices to boost demand
    • 9.2.3 CANADA
      • 9.2.3.1 Growing need to curtail healthcare costs to drive market
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Favorable reimbursements for technological innovation to propel market
    • 9.3.3 UK
      • 9.3.3.1 Government support for AI implementation to boost demand
    • 9.3.4 FRANCE
      • 9.3.4.1 Implementation of ETAPES program to fuel market
    • 9.3.5 ITALY
      • 9.3.5.1 Growing focus on digital transformation for value-centric patient care to drive market
    • 9.3.6 SPAIN
      • 9.3.6.1 Rising funding investments for digital health plans to boost market
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 CHINA
      • 9.4.2.1 Shortage of physicians and growing focus on RPM solutions to support market growth
    • 9.4.3 JAPAN
      • 9.4.3.1 Rising geriatric population and subsequent rise in preventive care to drive market
    • 9.4.4 INDIA
      • 9.4.4.1 Expanding target patient population to drive market
    • 9.4.5 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Growing focus on telehealth consultations to drive market
    • 9.5.3 MEXICO
      • 9.5.3.1 Improvements in healthcare infrastructure to boost demand
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
  • 9.7 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 9.7.1 GCC COUNTRIES
      • 9.7.1.1 Government initiatives for investments in RPM solutions to support market growth
    • 9.7.2 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET
  • 10.3 REVENUE ANALYSIS, 2019-2023
  • 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Component footprint
      • 10.5.5.4 Indication footprint
      • 10.5.5.5 End-user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 10.6.5.1 Detailed list of key startups/SMEs
      • 10.6.5.2 Competitive benchmarking of startups/SMEs
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS
    • 10.7.1 FINANCIAL METRICS
    • 10.7.2 COMPANY VALUATION
  • 10.8 BRAND/SOFTWARE COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS
    • 10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 KONINKLIJKE PHILIPS N.V.
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products/Services offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product/Service launches & approvals
        • 11.1.1.3.2 Deals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Key strengths
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 OMRON HEALTHCARE, INC. (SUBSIDIARY OF OMRON CORPORATION)
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products/Services offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product/Service launches
        • 11.1.2.3.2 Deals
        • 11.1.2.3.3 Other developments
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Key strengths
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 MEDTRONIC
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products/Services offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product/Service approvals
        • 11.1.3.3.2 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Key strengths
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 GE HEALTHCARE
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products/Services offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Product/Service launches & approvals
        • 11.1.4.3.2 Deals
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Key strengths
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses & competitive threats
    • 11.1.5 ABBOTT
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products/Services offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Product/Service launches
        • 11.1.5.3.2 Deals
        • 11.1.5.3.3 Expansions
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Key strengths
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses & competitive threats
    • 11.1.6 ORACLE
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products/Services offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Deals
    • 11.1.7 BOSTON SCIENTIFIC CORPORATION
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products/Services offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Product/Service launches & enhancements
        • 11.1.7.3.2 Deals
        • 11.1.7.3.3 Expansions
    • 11.1.8 NIHON KOHDEN CORPORATION
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products/Services offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Product/Service launches
        • 11.1.8.3.2 Deals
        • 11.1.8.3.3 Expansions
    • 11.1.9 SIEMENS HEALTHINEERS AG
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products/Services offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Product/Service launches & approvals
        • 11.1.9.3.2 Deals
    • 11.1.10 BAXTER
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products/Services offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Product/Service launches & approvals
        • 11.1.10.3.2 Deals
    • 11.1.11 BIOBEAT
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products/Services offered
      • 11.1.11.3 Recent developments
        • 11.1.11.3.1 Product/Service launches & approvals
        • 11.1.11.3.2 Deals
    • 11.1.12 BIOTRONIK
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products/Services offered
      • 11.1.12.3 Recent developments
        • 11.1.12.3.1 Product/Service launches & approvals
        • 11.1.12.3.2 Deals
    • 11.1.13 VITALCONNECT
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products/Services offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Product/Service launches
        • 11.1.13.3.2 Deals
        • 11.1.13.3.3 Other developments
    • 11.1.14 VIVALNK, INC.
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products/Services offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Product/Service launches & enhancements
        • 11.1.14.3.2 Deals
    • 11.1.15 CLEARARCH, INC.
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products/Services offered
      • 11.1.15.3 Recent developments
        • 11.1.15.3.1 Product/Service launches
        • 11.1.15.3.2 Deals
    • 11.1.16 OPTUM, INC. (VIVIFY HEALTH, PART OF OPTUM)
      • 11.1.16.1 Business overview
      • 11.1.16.2 Products/Services offered
    • 11.1.17 BLUE SPARK TECHNOLOGIES, INC.
      • 11.1.17.1 Business overview
      • 11.1.17.2 Products/Services offered
      • 11.1.17.3 Recent developments
        • 11.1.17.3.1 Product/Service launches
        • 11.1.17.3.2 Deals
        • 11.1.17.3.3 Other developments
    • 11.1.18 LIGHTBEAM
      • 11.1.18.1 Business overview
      • 11.1.18.2 Products/Services offered
      • 11.1.18.3 Recent developments
        • 11.1.18.3.1 Deals
    • 11.1.19 CLOUD DIAGNOSTICS CANADA ULC
      • 11.1.19.1 Business overview
      • 11.1.19.2 Products/Services offered
      • 11.1.19.3 Recent developments
        • 11.1.19.3.1 Product/Service launches
        • 11.1.19.3.2 Deals
    • 11.1.20 TELADOC HEALTH, INC.
      • 11.1.20.1 Business overview
      • 11.1.20.2 Products/Services offered
      • 11.1.20.3 Recent developments
        • 11.1.20.3.1 Product/Service launches
        • 11.1.20.3.2 Deals
    • 11.1.21 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.
      • 11.1.21.1 Business overview
      • 11.1.21.2 Products/Services offered
      • 11.1.21.3 Recent developments
        • 11.1.21.3.1 Product/Service launches
  • 11.2 OTHER PLAYERS
    • 11.2.1 CARESIMPLE INC.
    • 11.2.2 TIMEDOC, INC.
    • 11.2.3 MD REVOLUTION INC.
    • 11.2.4 OPTIMIZE HEALTH, INC.
    • 11.2.5 HEALTH RECOVERY SOLUTIONS

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 2 FACTOR ANALYSIS
  • TABLE 3 RISK ASSESSMENT: REMOTE PATIENT MONITORING MARKET
  • TABLE 4 REMOTE PATIENT MONITORING MARKET: IMPACT ANALYSIS
  • TABLE 5 RECENT DEVELOPMENTS OF AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2022-DECEMBER 2024
  • TABLE 6 TOP 5 HEALTHCARE ORGANIZATIONS IMPACTED BY SECURITY BREACHES
  • TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 NORTH AMERICA: REGULATORY ANALYSIS
  • TABLE 13 EUROPE: REGULATORY ANALYSIS
  • TABLE 14 ASIA PACIFIC: REGULATORY ANALYSIS
  • TABLE 15 MIDDLE EAST & AFRICA: REGULATORY ANALYSIS
  • TABLE 16 LATIN AMERICA: REGULATORY ANALYSIS
  • TABLE 17 INDICATIVE PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2023)
  • TABLE 18 AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY DEVICE (2023)
  • TABLE 19 INDICATIVE PRICE OF REMOTE PATIENT MONITORING DEVICES, BY REGION, 2023 (USD)
  • TABLE 20 REMOTE PATIENT MONITORING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 21 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING
  • TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING, BY END USERS
  • TABLE 23 KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING
  • TABLE 24 UNMET NEEDS IN REMOTE PATIENT MONITORING MARKET
  • TABLE 25 END-USER EXPECTATIONS IN REMOTE PATIENT MONITORING MARKET
  • TABLE 26 CPT CODES AND REIMBURSEMENT ANALYSIS OF US RPM MARKET
  • TABLE 27 REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 28 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 29 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 30 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 31 NEUROLOGICAL MONITORING DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 32 RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 33 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 34 FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 35 WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 36 MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 37 PULSE OXIMETER DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 38 THERMOMETERS MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 39 OTHER MONITORING DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 40 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 41 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (THOUSAND UNITS)
  • TABLE 42 WEARABLE DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 43 IMPLANTABLE DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 44 HANDHELD & PORTABLE DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 45 OTHER DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 46 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 47 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 48 ON-PREMISE MODELS MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 49 CLOUD-BASED MODELS MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 50 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 51 SYNCHRONOUS TRANSMISSION MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 52 ASYNCHRONOUS TRANSMISSION MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 53 REMOTE PATIENT MONITORING MARKET FOR SERVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 54 REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 55 REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 56 REMOTE PATIENT MONITORING MARKET FOR CARDIOLOGY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 57 REMOTE PATIENT MONITORING MARKET FOR NEUROLOGY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 58 REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 59 REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 60 REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY DISEASES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 61 REMOTE PATIENT MONITORING MARKET FOR WELLNESS IMPROVEMENT, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 62 REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 63 REMOTE PATIENT MONITORING MARKET FOR OTHER INDICATIONS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 64 REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 65 REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 66 REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 67 REMOTE PATIENT MONITORING MARKET FOR HOSPITALS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 68 REMOTE PATIENT MONITORING MARKET FOR ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 69 REMOTE PATIENT MONITORING MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 70 REMOTE PATIENT MONITORING MARKET FOR HOME HEALTHCARE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 71 REMOTE PATIENT MONITORING MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 72 REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 73 REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 74 REMOTE PATIENT MONITORING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 75 REMOTE PATIENT MONITORING MARKET FOR MEDTECH COMPANIES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 76 REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 77 REMOTE PATIENT MONITORING MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 79 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 80 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 83 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 84 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 85 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 86 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 87 US: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 88 US: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 89 US: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 90 US: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 91 US: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 92 US: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 93 US: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 94 CANADA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 95 CANADA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 96 CANADA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 97 CANADA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 98 CANADA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 99 CANADA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 100 CANADA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 101 CANADA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 102 EUROPE: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 103 EUROPE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 104 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 105 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 106 EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 107 EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 108 EUROPE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 109 EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 110 EUROPE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 111 GERMANY: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 112 GERMANY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 113 GERMANY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 114 GERMANY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 115 GERMANY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 116 GERMANY: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 117 GERMANY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 118 GERMANY: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 119 UK: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 120 UK: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 121 UK: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 122 UK: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 123 UK: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 124 UK: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 125 UK: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 126 UK: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 127 FRANCE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 128 FRANCE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 129 FRANCE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 130 FRANCE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 131 FRANCE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 132 FRANCE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 133 FRANCE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 134 FRANCE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 135 ITALY: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 136 ITALY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 137 ITALY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 138 ITALY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 139 ITALY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 140 ITALY: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 141 ITALY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 142 ITALY: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 143 SPAIN: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 144 SPAIN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 145 SPAIN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 146 SPAIN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 147 SPAIN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 148 SPAIN: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 149 SPAIN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 150 SPAIN: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 151 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 152 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 153 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 154 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 155 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 156 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 157 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 158 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 163 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 168 CHINA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 169 CHINA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 170 CHINA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 171 CHINA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 172 CHINA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 173 CHINA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 174 CHINA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 175 CHINA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 176 JAPAN: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 177 JAPAN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 178 JAPAN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 179 JAPAN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 180 JAPAN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 181 JAPAN: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 182 JAPAN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 183 JAPAN: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 184 INDIA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 185 INDIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 186 INDIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 187 INDIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 188 INDIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 189 INDIA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 190 INDIA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 191 INDIA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 192 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 193 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 194 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 195 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 196 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 197 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 198 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 199 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 200 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 201 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 202 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 203 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 204 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 205 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 206 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 207 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 208 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 209 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 210 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 211 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 212 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 213 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 214 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 215 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 216 BRAZIL: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 217 MEXICO: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 218 MEXICO: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 219 MEXICO: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 220 MEXICO: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 221 MEXICO: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 222 MEXICO: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 223 MEXICO: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 224 MEXICO: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 225 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 226 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 227 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 228 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 229 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 230 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 231 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 232 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 233 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 234 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 235 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 236 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 237 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 238 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 239 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 240 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 241 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 242 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 243 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 244 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 245 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 246 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 247 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 248 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 249 GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 250 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 251 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 252 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 253 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022-2030 (USD MILLION)
  • TABLE 254 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 255 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 256 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 257 REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 258 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, JANUARY 2021-JANUARY 2025
  • TABLE 259 REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION
  • TABLE 260 REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT
  • TABLE 261 REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT
  • TABLE 262 REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT
  • TABLE 263 REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT
  • TABLE 264 REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 265 REMOTE PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
  • TABLE 266 REMOTE PATIENT MONITORING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 267 REMOTE PATIENT MONITORING MARKET: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 268 REMOTE PATIENT MONITORING MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 269 REMOTE PATIENT MONITORING MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 270 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 271 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED
  • TABLE 272 KONINKLIJKE PHILIPS N.V.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 273 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 274 OMRON CORPORATION: COMPANY OVERVIEW
  • TABLE 275 OMRON HEALTHCARE, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 276 OMRON HEALTHCARE, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 277 OMRON HEALTHCARE, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 278 OMRON HEALTHCARE, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 279 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 280 MEDTRONIC: PRODUCTS/SERVICES OFFERED
  • TABLE 281 MEDTRONIC: PRODUCT/SERVICE APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 282 MEDTRONIC: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 283 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 284 GE HEALTHCARE: PRODUCTS/SERVICES OFFERED
  • TABLE 285 GE HEALTHCARE: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 286 GE HEALTHCARE: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 287 ABBOTT: COMPANY OVERVIEW
  • TABLE 288 ABBOTT: PRODUCTS/SERVICES OFFERED
  • TABLE 289 ABBOTT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 290 ABBOTT: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 291 ABBOTT: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 292 ORACLE: COMPANY OVERVIEW
  • TABLE 293 ORACLE: PRODUCTS/SERVICES OFFERED
  • TABLE 294 ORACLE: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 295 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 296 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 297 BOSTON SCIENTIFIC CORPORATION: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 298 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 299 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 300 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 301 NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 302 NIHON KOHDEN CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 303 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 304 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 305 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 306 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED
  • TABLE 307 SIEMENS HEALTHINEERS AG: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 308 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 309 BAXTER: COMPANY OVERVIEW
  • TABLE 310 BAXTER: PRODUCTS/SERVICES OFFERED
  • TABLE 311 BAXTER: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 312 BAXTER: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 313 BIOBEAT: COMPANY OVERVIEW
  • TABLE 314 BIOBEAT: PRODUCTS/SERVICES OFFERED
  • TABLE 315 BIOBEAT: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 316 BIOBEAT: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 317 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 318 BIOTRONIK: PRODUCTS/SERVICES OFFERED
  • TABLE 319 BIOTRONIK: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 320 BIOTRONIK: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 321 VITALCONNECT: COMPANY OVERVIEW
  • TABLE 322 VITALCONNECT: PRODUCTS/SERVICES OFFERED
  • TABLE 323 VITALCONNECT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 324 VITALCONNECT: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 325 VITALCONNECT: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 326 VIVALNK, INC.: COMPANY OVERVIEW
  • TABLE 327 VIVALNK, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 328 VIVALNK, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 329 VIVALNK, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 330 CLEARARCH, INC.: COMPANY OVERVIEW
  • TABLE 331 CLEARARCH, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 332 CLEARARCH, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 333 CLEARARCH, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 334 OPTUM, INC.: COMPANY OVERVIEW
  • TABLE 335 OPTUM, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 336 BLUE SPARK TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 337 BLUE SPARK TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 338 BLUE SPARK TECHNOLOGIES, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 339 BLUE SPARK TECHNOLOGIES, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 340 BLUE SPARK TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 341 LIGHTBEAM: COMPANY OVERVIEW
  • TABLE 342 LIGHTBEAM: PRODUCTS/SERVICES OFFERED
  • TABLE 343 LIGHTBEAM: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 344 CLOUD DIAGNOSTICS CANADA ULC: COMPANY OVERVIEW
  • TABLE 345 CLOUD DIAGNOSTICS CANADA ULC: PRODUCTS/SERVICES OFFERED
  • TABLE 346 CLOUD DIAGNOSTICS CANADA ULC: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 347 CLOUD DIAGNOSTICS CANADA ULC: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 348 TELADOC HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 349 TELADOC HEALTH, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 350 TELADOC HEALTH, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 351 TELADOC HEALTH, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 352 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 353 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 354 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-JANUARY 2025

List of Figures

  • FIGURE 1 REMOTE PATIENT MONITORING MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 7 SUPPLY-SIDE MARKET ESTIMATION
  • FIGURE 8 REMOTE PATIENT MONITORING MARKET: REVENUE ESTIMATION APPROACH
  • FIGURE 9 BOTTOM-UP APPROACH: END-USER SPENDING ON REMOTE PATIENT MONITORING
  • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2028)
  • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 12 TOP-DOWN APPROACH
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 15 REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 REMOTE PATIENT MONITORING MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 REMOTE PATIENT MONITORING MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 18 TRANSFORMATION OF PATIENT CARE THROUGH DIGITIZATION TO PROPEL MARKET
  • FIGURE 19 HEALTHCARE PROVIDERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023)
  • FIGURE 20 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 21 EMERGING MARKETS TO GROW AT HIGHER CAGR DURING FORECAST PERIOD
  • FIGURE 22 REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 DIGITAL HEALTH FUNDING HISTORY, 2020-2024 (USD BILLION)
  • FIGURE 24 NUMBER OF DEALS IN DIGITAL HEALTH (2020-2024)
  • FIGURE 25 US: MEDICARE-CERTIFIED ASCS, BY STATE (AS OF SEPTEMBER 2024)
  • FIGURE 26 HEALTHCARE SECURITY BREACHES OF 500 + RECORDS, 2009-2024
  • FIGURE 27 HEALTHCARE SECURITY BREACHES, 2009-2023
  • FIGURE 28 REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 IMPORT OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2023 (USD THOUSAND)
  • FIGURE 31 EXPORTS OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2023 (USD THOUSAND)
  • FIGURE 32 IMPORT OF PRODUCTS UNDER HSN CODE: 9021, BY COUNTRY, 2023 (USD THOUSAND)
  • FIGURE 33 EXPORTS OF PRODUCTS UNDER HSN CODE: 9021, BY COUNTRY, 2023 (USD THOUSAND)
  • FIGURE 34 IMPORT OF PRODUCTS UNDER HSN CODE: 9022, BY COUNTRY, 2023 (USD THOUSAND)
  • FIGURE 35 EXPORTS OF PRODUCTS UNDER HSN CODE: 9022, BY COUNTRY, 2023 (USD THOUSAND)
  • FIGURE 36 REMOTE PATIENT MONITORING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 37 GLOBAL PATENT PUBLICATION TRENDS IN REMOTE PATIENT MONITORING MARKET, 2015-2024
  • FIGURE 38 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING PATENTS (JANUARY 2015-NOVEMBER 2024)
  • FIGURE 39 LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET (JANUARY 2015-NOVEMBER 2024)
  • FIGURE 40 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING
  • FIGURE 41 KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING, BY COMPONENT
  • FIGURE 42 POTENTIAL OF GENERATIVE AI/AI IN REMOTE PATIENT MONITORING ACROSS INDUSTRIES
  • FIGURE 43 NEW CANCER CASES IN US, 2024
  • FIGURE 44 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET SNAPSHOT
  • FIGURE 45 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET SNAPSHOT
  • FIGURE 46 REVENUE ANALYSIS OF KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, 2019-2023 (USD MILLION)
  • FIGURE 47 MARKET SHARE ANALYSIS OF KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET (2023)
  • FIGURE 48 REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 49 REMOTE PATIENT MONITORING MARKET: COMPANY FOOTPRINT
  • FIGURE 50 REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 51 EV/EBITDA OF KEY VENDORS
  • FIGURE 52 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 53 REMOTE PATIENT MONITORING MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • FIGURE 54 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
  • FIGURE 55 OMRON CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 56 MEDTRONIC: COMPANY SNAPSHOT (2023)
  • FIGURE 57 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 58 ABBOTT: COMPANY SNAPSHOT (2023)
  • FIGURE 59 ORACLE: COMPANY SNAPSHOT (2023)
  • FIGURE 60 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 61 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 62 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 63 BAXTER: COMPANY SNAPSHOT (2023)
  • FIGURE 64 TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2023)